Long Term Safety Study of Tanezumab in Chronic Low Back Pain

NCT00924664 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
849
Enrollment
INDUSTRY
Sponsor class

Stopped See termination reason in detailed description.

Conditions

Interventions

Sponsor

Pfizer